- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01951664
Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors
April 26, 2016 updated by: Sheila Ridner, Vanderbilt-Ingram Cancer Center
Treatment for head and neck cancer can result in marked musculo-skeletal impairment (MSI).
This study will examine the effects of Hatha Yoga as a therapeutic modality to address MSI.
Study Overview
Status
Completed
Conditions
Detailed Description
The use of aggressive treatment for head and neck cancer (HNC) particularly combined modality treatment regimens has resulted in an increase in survival.
Unfortunately, this improvement has come with a marked increase in acute and late-effects.
Acute HNC treatment-related toxicities have been clearly and extensively documented; however, data pertaining to adverse late-effects, those most likely to impact the survivor's long term symptom burden, functionality, and overall quality of life (QOL), are limited.
This pilot study will be conducted to examine the feasibility of tailored Hatha Yoga as a therapeutic modality to address MSI in patients who have survived HNC.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt-Ingram Cancer Center
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University School of Nursing
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- >/= 18 years of age
- >3 months post-treatment of HNC
- no active cancer
- ability to understand English in order to complete questionnaires
- willing to participate in the guided and home Yoga practice
- willing to drive to the study site
- willing and able to provide informed consent
- completed medically indicated physical therapy
- medical clearance by study medical oncologist
Exclusion Criteria:
- a prior cancer diagnosis within the past three years (except basal cell, surgically treated squamous cell skin cancer, early prostate cancer under observation)
- have received radiation therapy or chemotherapy for any condition other than primary HNC
- medical conditions that would prohibit the safe implementation of a Yoga practice (e.g., vertigo, dementia)
- active Yoga practice within the past 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Modified Yoga Program for HNC Survivors
Following the completion of baseline study measures, participants will be randomized to either do go directly into a Yoga program or to an 8 week wait-list control group.
Those in the yoga program will undergo an initial Yoga Evaluation.
Patients will receive customized yoga guided practice program, a home practice plan with ongoing modifications.
Instructors will assess compliance.
A satisfaction assessment is conducted at study-end.
|
Participants will undergo baseline objective and self-report study measures including: 1) ROM in the jaw, neck, and shoulders; 2) posture assessment; 3) pain, and 4) psychological distress.
The study measures will take 30-45 minutes to administer.
The evaluation includes an assessment of nine traditional Yoga components: energy, symptoms, emotions, posture, breathing patterns, gait, muscle/tissue quality, joint flexibility, and muscle strength.
Emphasis will be placed on the assessment of jaw/neck/shoulder MSI requiring Yoga practice modification of those poses that are unsafe or not feasible for a patient to perform.
Information from the evaluation will be used to establish the tailored Yoga program
The Yoga program has 5 components: 1) Awareness Practice to enhance self-awareness, 2)Poses - 16 core poses will be modified for each patient's specific needs, 3)Breath Work - breath awareness and proper breathing for maximum benefit, 4)Relaxation - alternating between methods of relaxation, 5)Mediation - awareness and practice of inner silence
To enhance fidelity, a standardized Yoga intervention was chosen that includes postures, meditation, relaxation, and breath work.
To ensure safety, the practice plan for each patient will be reviewed prior to initiation.
All MSI limitations will be discussed, and appropriate adaptive techniques will be formulated.
Qualitative techniques will be used to describe and categorize the types of impairment and modifications.
By developing a catalog of impairments and suitable modifications, a safe and uniform Yoga program can be further tested and widely disseminated.
Data collection methods used to assess efficacy include physical measurement/examination, jaw range of motion (device) - scales to measure opening, cervical range of motion(Device), Shoulder Range of Motion - Goniometer, Posture - Wall Zone Grid, self-reported surveys for physical symptoms, pain, psychological symptoms, anxiety, depression and quality of life
|
|
Active Comparator: Wait list control
Those in the wait list group will have the same assessments as those in the yoga program over the same period of time.
|
Participants will undergo baseline objective and self-report study measures including: 1) ROM in the jaw, neck, and shoulders; 2) posture assessment; 3) pain, and 4) psychological distress.
The study measures will take 30-45 minutes to administer.
Data collection methods used to assess efficacy include physical measurement/examination, jaw range of motion (device) - scales to measure opening, cervical range of motion(Device), Shoulder Range of Motion - Goniometer, Posture - Wall Zone Grid, self-reported surveys for physical symptoms, pain, psychological symptoms, anxiety, depression and quality of life
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients who complete a modified Yoga program for HNC survivors
Time Frame: at 8 weeks
|
Number of patients that complete an 8-week course of guided yoga sessions and that complete a Participant Practice Log to document their non-guided home yoga sessions
|
at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in range of motion (ROM) jaw maximal inter-incisoral opening
Time Frame: at 8 weeks
|
Change in ROM from baseline in the jaw maximal inter-incisoral opening, measured in millimeters (mm)
|
at 8 weeks
|
|
Change in cervical ROM
Time Frame: at 8 weeks
|
Change from baseline in cervical ROM, measured in degrees of neck movement
|
at 8 weeks
|
|
Change in head and neck-related treatment systems
Time Frame: at 8 weeks
|
Change from baseline in the Vanderbilt Head and Neck Symptom Survey: 9 questions on treatment-related symptoms with 0 = least amount of problems to 10 = most amount of problems.
Higher scores indicate increased treatment-related distress
|
at 8 weeks
|
|
Change in Brief Pain Inventory
Time Frame: at 8 weeks
|
Change from baseline in scores for the Brief Pain Inventory: 9 items with 0 = no pain to 10 = pain as bad as you can imagine.
Higher sum of scores indicate greater pain burden
|
at 8 weeks
|
|
Change in Body Image Quality of Life Inventory
Time Frame: at 8 weeks
|
Change from baseline in scores in the Change in Body Image Quality of Life Inventory.
18 questions with minus 3 = very negative effect to plus 3 = very positive effect.
sum of scores with higher scores indicating a more positive body image
|
at 8 weeks
|
|
Change in Anxiety and Depression Scale
Time Frame: 8 weeks
|
Change from baseline in scores on the Hospital Anxiety and Depression Inventory with a score of >/= 8 as possible cause for mental health referral
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Barbara Murphy, MD, Vanderbilt-Ingram Cancer Center
- Principal Investigator: Sheila H Ridner, PhD, RN, Vanderbilt University School of Nursing
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2013
Primary Completion (Actual)
October 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
September 23, 2013
First Submitted That Met QC Criteria
September 23, 2013
First Posted (Estimate)
September 27, 2013
Study Record Updates
Last Update Posted (Estimate)
April 27, 2016
Last Update Submitted That Met QC Criteria
April 26, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VICC SUPP 1282
- 1R21CA173202-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Mayo ClinicCompletedCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
West China HospitalNot yet recruitingHead and Neck Cancer | Malignant Neoplasm | Advanced Head and Neck Carcinoma | Head &Amp; Neck Cancer
-
Fondazione IRCCS Policlinico San Matteo di PaviaNestle Health Science; Akern SrlCompletedHead-neck CancerItaly
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
University of California, San FranciscoCompleted
-
Radboud University Medical CenterUnknown
-
Chinook Therapeutics, Inc. (formerly Aduro)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedHead And Neck CancerUnited States
Clinical Trials on Baseline Study Measures
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); American Cancer Society, Inc.CompletedEndometrial CancerUnited States
-
Clinica Universidad de Navarra, Universidad de...RecruitingObesity | Breast Cancer | Health, SubjectiveSpain
-
Zhujiang HospitalCompletedCholecystitis | Cholelithiasis | Gallbladder Polyps | MAFLDChina
-
University of ChicagoCompleted
-
General Hospital of Ningxia Medical UniversityCompleted
-
Washington University School of MedicineCompleted
-
Johns Hopkins UniversityResMed; Ventus Medical, Inc.CompletedSleep Apnea, ObstructiveUnited States
-
University Hospital Inselspital, BerneCompletedBreast CancerSwitzerland
-
Riphah International UniversityRecruitingHemiplegic Cerebral PalsyPakistan
-
Xuanwu Hospital, BeijingNot yet recruitingCerebral Venous Sinus ThrombosisChina